Literature DB >> 12737130

Progression of autoimmune thyroiditis in an HIV-infected woman on HAART.

C R Rosenfeld1, L H Calabrese.   

Abstract

Changes in immunoregulation, among other factors, may initiate or exacerbate autoimmune thyroiditis. Strikingly high titers of antithyroid peroxidase antibodies have been found in HIV-infected patients, and, according to some studies, these increase further as HIV disease progresses. The pathogenesis of autoimmune thyroiditis is not totally understood, but activated CD4+ cells predominate in the infiltrate and are believed to be central to the process. Some investigators have postulated that endocrinologic autoimmunity might result from incomplete or unbalanced immune restoration with highly active antiretroviral therapy (HAART). The case presented here suggests progression from euthyroid Hashimoto's thyroiditis to hypothyroidism after initiation of HAART.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12737130

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  3 in total

Review 1.  HIV & immune reconstitution inflammatory syndrome (IRIS).

Authors:  Surendra K Sharma; Manish Soneja
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 2.  Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.

Authors:  Devesh J Dhasmana; Keertan Dheda; Pernille Ravn; Robert J Wilkinson; Graeme Meintjes
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in premenopausal HIV infected females at NAUTH, Nnewi, Nigeria.

Authors:  Nkiruka Rose Ukibe; Solomon Nwabueze Ukibe; Obiageli Fidelia Emelumadu; Chinedum Charles Onyenekwe; Joseph Eberendu Ahaneku; Anthony Osita Igwegbe; Ifeoma Nwamaka Monago; Amobi Linus Ilika
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.